Drug Shortages

Below is a list of current and anticipated ophthalmic drug shortages gathered from Health Canada.
The table is updated daily.

Last Updated: 2021-09-20 00:01:17

Drug Name Drug Status Last Updated DIN Type Anticipated Start Date Estimated End Date Actual Start Date Actual End Date Shortage Reason
VISUDYNE Marketed 2020-06-17 02242367 Shortage 2022-01-31 2020-08-01 Disruption of the manufacture of the drug.
DIOFLUOR STRIPS Marketed 2020-08-05 02160773 Shortage 2020-12-01 2021-03-22 Shortage of an active ingredient.
ACT LATANOPROST/TIMOLOL Marketed 2021-09-09 02436256 Shortage 2021-09-30 2021-08-27 Disruption of the manufacture of the drug.
APO-OLOPATADINE Marketed 2020-04-03 02305054 Shortage 2020-06-01 Disruption of the manufacture of the drug.
APO-TIMOP Marketed 2018-03-08 00755834 Shortage 2021-10-15 Disruption of the manufacture of the drug.
ATROPINE Marketed 2019-04-06 02023695 Shortage 2020-11-01 Delay in shipping of the drug.
ERYTHROMYCIN OPHTHALMIC OINTMENT USP Marketed 2021-07-08 02326663 Shortage 2021-10-29 2017-03-09 Disruption of the manufacture of the drug.
MINIMS ATROPINE SULPHATE Marketed 2020-12-09 02148358 Shortage 2021-11-19 2021-08-16 Other (Please describe in comments)
OCUFLOX Marketed 2020-04-03 02143291 Shortage 2022-01-31 2021-04-06 Disruption of the manufacture of the drug.
ODAN-TROPICAMIDE Marketed 2021-09-09 00622885 Shortage 2016-04-15 Disruption of the manufacture of the drug.
TEVA-CYCLOSPORINE Marketed 2019-05-04 02462486 Shortage 2021-10-31 2021-07-21 Demand increase for the drug.
TIMOLOL MALEATE-EX Marketed 2018-03-08 02242276 Shortage 2021-10-08 2019-12-02 Delay in shipping of the drug.
VIROPTIC Marketed 2020-11-09 00687456 Shortage 2017-06-14 Shortage of an active ingredient.
VISTITAN Marketed 2020-04-03 02429063 Shortage 2021-11-05 2021-09-13 Disruption of the manufacture of the drug.

- Minimize

+ Maximize

:
: